Transformers One' has locked in its premiere date for Paramount+. Pic is set to stream in the U.S. and Canada beginning ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
Corwin covers the Healthcare sector, focusing on stocks such as PTC Therapeutics, Zevra Therapeutics, and Poseida Therapeutics. According to TipRanks, Corwin has an average return of 4.1% and a 50.79% ...
PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...
Summit Therapeutics and its Chinese partner Akeso have a few competitors now. Merck, the maker of the drug they're trying to ...
The ICC has launched a new logo for the 2025 ICC Champions Trophy. Pakistan is the confirmed host. India's participation is ...
Currently, the analyst consensus on PTC Therapeutics is a Hold with an average price target of $42.40, a -5.1% downside from current levels. In a report issued on November 7, RBC Capital also ...